LIVER TRANSPLANTATION FOR TYPE I GLYCOGEN STORAGE DISEASE

J. Jeffrey Malatack, Shunzaburo Iwatsuki, J. Carlton Gartner, Thomas Roe, David N. Finegold, Byers Wendell Shaw Jr, Basil J. Zitelli, Thomas E. Starzl

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

A 161/2-year-old girl with type I glycogen storage disease was treated by orthotopic liver transplantation under cyclosporin/steroid immunosuppression. All metabolic stigmata of the disease were relieved and 1 year postoperatively she follows a normal diet and lifestyle.

Original languageEnglish (US)
Pages (from-to)1073-1075
Number of pages3
JournalThe Lancet
Volume321
Issue number8333
DOIs
StatePublished - May 14 1983

Fingerprint

Glycogen Storage Disease Type I
Christianity
Metabolic Diseases
Liver Transplantation
Immunosuppression
Cyclosporine
Life Style
Steroids
Diet

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Jeffrey Malatack, J., Iwatsuki, S., Carlton Gartner, J., Roe, T., Finegold, D. N., Shaw Jr, B. W., ... Starzl, T. E. (1983). LIVER TRANSPLANTATION FOR TYPE I GLYCOGEN STORAGE DISEASE. The Lancet, 321(8333), 1073-1075. https://doi.org/10.1016/S0140-6736(83)91910-4

LIVER TRANSPLANTATION FOR TYPE I GLYCOGEN STORAGE DISEASE. / Jeffrey Malatack, J.; Iwatsuki, Shunzaburo; Carlton Gartner, J.; Roe, Thomas; Finegold, David N.; Shaw Jr, Byers Wendell; Zitelli, Basil J.; Starzl, Thomas E.

In: The Lancet, Vol. 321, No. 8333, 14.05.1983, p. 1073-1075.

Research output: Contribution to journalArticle

Jeffrey Malatack, J, Iwatsuki, S, Carlton Gartner, J, Roe, T, Finegold, DN, Shaw Jr, BW, Zitelli, BJ & Starzl, TE 1983, 'LIVER TRANSPLANTATION FOR TYPE I GLYCOGEN STORAGE DISEASE', The Lancet, vol. 321, no. 8333, pp. 1073-1075. https://doi.org/10.1016/S0140-6736(83)91910-4
Jeffrey Malatack J, Iwatsuki S, Carlton Gartner J, Roe T, Finegold DN, Shaw Jr BW et al. LIVER TRANSPLANTATION FOR TYPE I GLYCOGEN STORAGE DISEASE. The Lancet. 1983 May 14;321(8333):1073-1075. https://doi.org/10.1016/S0140-6736(83)91910-4
Jeffrey Malatack, J. ; Iwatsuki, Shunzaburo ; Carlton Gartner, J. ; Roe, Thomas ; Finegold, David N. ; Shaw Jr, Byers Wendell ; Zitelli, Basil J. ; Starzl, Thomas E. / LIVER TRANSPLANTATION FOR TYPE I GLYCOGEN STORAGE DISEASE. In: The Lancet. 1983 ; Vol. 321, No. 8333. pp. 1073-1075.
@article{7b8ea2842ade4013a57e16607e5357e2,
title = "LIVER TRANSPLANTATION FOR TYPE I GLYCOGEN STORAGE DISEASE",
abstract = "A 161/2-year-old girl with type I glycogen storage disease was treated by orthotopic liver transplantation under cyclosporin/steroid immunosuppression. All metabolic stigmata of the disease were relieved and 1 year postoperatively she follows a normal diet and lifestyle.",
author = "{Jeffrey Malatack}, J. and Shunzaburo Iwatsuki and {Carlton Gartner}, J. and Thomas Roe and Finegold, {David N.} and {Shaw Jr}, {Byers Wendell} and Zitelli, {Basil J.} and Starzl, {Thomas E.}",
year = "1983",
month = "5",
day = "14",
doi = "10.1016/S0140-6736(83)91910-4",
language = "English (US)",
volume = "321",
pages = "1073--1075",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8333",

}

TY - JOUR

T1 - LIVER TRANSPLANTATION FOR TYPE I GLYCOGEN STORAGE DISEASE

AU - Jeffrey Malatack, J.

AU - Iwatsuki, Shunzaburo

AU - Carlton Gartner, J.

AU - Roe, Thomas

AU - Finegold, David N.

AU - Shaw Jr, Byers Wendell

AU - Zitelli, Basil J.

AU - Starzl, Thomas E.

PY - 1983/5/14

Y1 - 1983/5/14

N2 - A 161/2-year-old girl with type I glycogen storage disease was treated by orthotopic liver transplantation under cyclosporin/steroid immunosuppression. All metabolic stigmata of the disease were relieved and 1 year postoperatively she follows a normal diet and lifestyle.

AB - A 161/2-year-old girl with type I glycogen storage disease was treated by orthotopic liver transplantation under cyclosporin/steroid immunosuppression. All metabolic stigmata of the disease were relieved and 1 year postoperatively she follows a normal diet and lifestyle.

UR - http://www.scopus.com/inward/record.url?scp=0020540410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020540410&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(83)91910-4

DO - 10.1016/S0140-6736(83)91910-4

M3 - Article

VL - 321

SP - 1073

EP - 1075

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8333

ER -